These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 11313195)

  • 1. Avascular necrosis of both femoral heads in an HIV-infected patient receiving protease inhibitors.
    Franzen C; Salzberger B; Fätkenheuer G
    Eur J Med Res; 2001 Feb; 6(2):83-4. PubMed ID: 11313195
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Possible complication of HIV therapy. Protease inhibitor-induced femur head necrosis].
    Porsch M; König DP; Popken F
    MMW Fortschr Med; 2001 Apr; 143 Suppl 1():90-1. PubMed ID: 11373793
    [No Abstract]   [Full Text] [Related]  

  • 3. [Avascular necrosis of the femoral head among patients infected with the human immunodeficiency virus on antiretroviral therapy].
    Valencia ME; Moreno V; Soriano V; Blanco F; González-Lahoz J
    Enferm Infecc Microbiol Clin; 2001 Dec; 19(10):503-5. PubMed ID: 11844460
    [No Abstract]   [Full Text] [Related]  

  • 4. [Avascular osteonecrosis of femoral head and neck in an AIDS patient].
    Villafañe MF; Corti ME; Candela M; Perez Bianco R; Tezanos Pinto M
    Medicina (B Aires); 2004; 64(2):149-51. PubMed ID: 15628304
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Osteonecrosis in six HIV-infected patients receiving highly active antiretroviral therapy.
    Molia AC; Strady C; Rouger C; Beguinot IM; Berger JL; Trenque TC
    Ann Pharmacother; 2004 Dec; 38(12):2050-4. PubMed ID: 15507502
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human immunodeficiency virus and avascular necrosis of the femoral head: a case report.
    Caĝatay AA; Kücükkaya R; Akyildiz M; Berk H; Cagatay Y; Yildirmak T; Ozsüt H; Eraksoy H; Calangu S
    Chin Med J (Engl); 2004 Sep; 117(9):1437-40. PubMed ID: 15377446
    [No Abstract]   [Full Text] [Related]  

  • 7. Stent implantation for acute left main coronary artery occlusion in an HIV-infected patient on protease inhibitors.
    Boccara F; Teiger E; Cohen A
    J Invasive Cardiol; 2002 Jun; 14(6):343-6. PubMed ID: 12042630
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antiretroviral treatment. HIV infection in adults: better-defined first-line treatment.
    Prescrire Int; 2004 Aug; 13(72):144-50. PubMed ID: 15532140
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Osteonecrosis of the femoral heads and human immunodeficiency virus.
    Harzy T; Berrady R; Tizniti S; Bono W
    J Clin Rheumatol; 2008 Jun; 14(3):190. PubMed ID: 18525445
    [No Abstract]   [Full Text] [Related]  

  • 10. Protease inhibitor plasma concentrations in HIV antiretroviral therapy.
    Justesen US
    Dan Med Bull; 2008 Nov; 55(4):165-85. PubMed ID: 19232158
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [HIV infection, antiretroviral therapy, and endothelium].
    Hürlimann D; Weber R; Enseleit F; Lüscher TF
    Herz; 2005 Sep; 30(6):472-80. PubMed ID: 16170677
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of metformin or gemfibrozil on the lipodystrophy of HIV-infected patients receiving protease inhibitors.
    Martínez E; Domingo P; Ribera E; Milinkovic A; Arroyo JA; Conget I; Pérez-Cuevas JB; Casamitjana R; de Lazzari E; Bianchi L; Montserrat E; Roca M; Burgos R; Arnaiz JA; Gatell JM
    Antivir Ther; 2003 Oct; 8(5):403-10. PubMed ID: 14640387
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of discontinuing stavudine or protease inhibitor therapy on human immunodeficiency virus-related fat redistribution evaluated by dual-energy x-ray absorptiometry.
    Tavassoli N; Bagheri H; Sommet A; Delpierre C; Marion-Latard F; Massip P; Aquilina C; Bonnet E; Obadia M; Labau E; Montastruc JL; Bernard J
    Pharmacotherapy; 2006 Feb; 26(2):154-61. PubMed ID: 16466321
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Concomitant use of gastric acid-reducing agents is frequent among HIV-1-infected patients receiving protease inhibitor-based highly active antiretroviral therapy.
    van Lunzen J; Liess H; Arastéh K; Walli R; Daut B; Schürmann D
    HIV Med; 2007 May; 8(4):220-5. PubMed ID: 17461849
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of treatment with protease inhibitors on aortic stiffness in adult patients with human immunodeficiency virus infection.
    Schillaci G; De Socio GV; Pirro M; Savarese G; Mannarino MR; Baldelli F; Stagni G; Mannarino E
    Arterioscler Thromb Vasc Biol; 2005 Nov; 25(11):2381-5. PubMed ID: 16123321
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Bilateral hip necrosis, corticoids, and human immunodeficiency virus protease inhibitors].
    Manero FJ; Sesma J; Arazo P
    Enferm Infecc Microbiol Clin; 2001 Jan; 19(1):34-5. PubMed ID: 11256248
    [No Abstract]   [Full Text] [Related]  

  • 17. Avascular necrosis of the femoral head in HIV infected patients.
    Matos MA; Alencar RW; Matos SS
    Braz J Infect Dis; 2007 Feb; 11(1):31-4. PubMed ID: 17625723
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antiretroviral therapy with or without protease inhibitors impairs postprandial TAG hydrolysis in HIV-infected men.
    Ware LJ; Jackson AG; Wootton SA; Burdge GC; Morlese JF; Moyle GJ; Jackson AA; Gazzard BG
    Br J Nutr; 2009 Oct; 102(7):1038-46. PubMed ID: 19480729
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effects of antiretroviral protease inhibitors on serum lipid levels in HIV-infected patients.
    Chang ES; Tetreault DD; Liu YT; Beall GN
    J Am Diet Assoc; 2001 Jun; 101(6):687-9. PubMed ID: 11424549
    [No Abstract]   [Full Text] [Related]  

  • 20. Considerations in selecting protease inhibitor therapy.
    Boyle BA; Elion RA; Moyle GJ; Cohen CJ
    AIDS Rev; 2004; 6(4):218-25. PubMed ID: 15700620
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.